According to FutureWise analysis, the market for Adoptive Cell Therapy for Cancer Treatment is expected to grow at a CAGR of 21.22% over the forecast period of 2023-2031.
Adoptive cell therapy, also called cellular immunotherapy, is a treatment that uses the cells of the immune system to eliminate cancer. The primary goal of ACT is to develop new ways to generate immune cells specifically targeted to fight cancer. Adoptive cell therapy (ACT) is a rapidly growing anti-cancer strategy that has shown assurance in treating various cancer types. ACT can be classified into three different types with each mechanism of action, including tumor-infiltrating lymphocytes (TILs), genetically engineered immune cells, and dendritic cells (DCs) vaccines. With the advancement of cell culture and genetic engineering techniques, ACT has been used in clinics to treat malignant hematological diseases, and many new ACT-based regimens are in different stages of clinical trials. Two main types of cells used in adoptive cell therapy are T cells and natural killer (NK) cells.
There are two types of T-cell transfer therapy: TIL (tumor-infiltrating lymphocytes) therapy and CAR T-cell therapy. Both involve collecting own immune cells, growing a large number of these cells in the lab, and then giving the cells back through a needle in the vein. The process of developing T cells in the lab may take 2 to 8 weeks. During this period, an individual may undergo chemotherapy and radiation therapy to eliminate other immune cells. The Reduction of immune cells helps the cultured T cells to be more efficient. After these treatments, the T cells cultivated in the laboratory will be delivered through intravenous infusion.
FutureWise Market Research has published a report that provides an insightful adoptive cell therapy for cancer treatment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, adoptive cell therapy for cancer treatment market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.